Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2020 | Story André Damons
Bongani Mayosi Prize Latest News
Drs Kaamilah Joosub (in front) and Lynette Upman, medical students in the Faculty of Health Sciences at the UFS, are the winners of the first Bongani Mayosi Medical Students Academic Prize for final-year medical students.

Two final-year medical students from the University of the Free State (UFS) became the first recipients of the prestigious Bongani Mayosi Medical Students Academic Prize which was bestowed on them 10 days before their graduation.

Drs Kaamilah Joosub and Lynette Upman, two final-year medical students in the Faculty of Health Sciences at the UFS are the first medical students from the university to be awarded the prize.This is the first year it has been awarded.

Drs Joosub and Upman received their awards at a function on Friday (4 December 2020) from Prof Hanneke Brits, Phase III chair and specialist in the Department of Family Medicine, on behalf of Prof Gert van Zyl, Dean of the Faculty of Health Sciences.

The Faculty of Health Sciences will host a virtual graduation on 14 December 2020.

Prestigious national award

The Bongani Mayosi Medical Students Academic Prize is a prestigious national award which aims to recognise final-year medical students who epitomise the academic, legendary, and altruistic life of Mayosi. The awards are presented to final-year MB ChB students from all South African medical faculties. Each student is allowed one vote for one classmate who, in their private opinion, best balances:

  • Academic achievement
  • Emotional intelligence ‑ good interpersonal skills
  • Social accountability ‑ the ability to respond helpfully to the needs of others

Winners are determined by the highest number of digital votes, with the first-prize winner receiving R6 000 and second prize coming in at R4 000.

Dr Lynette van der Merwe, undergraduate medical programme director in the School of Clinical Medicine at UFS, commented that Drs Joosub and Upman are worthy winners, as they have continuously exemplified the ideals recognised by this award during their undergraduate training.

The School of Clinical Medicine is very proud of its newest Kovsie doctors who successfully completed the academic year despite the immense challenges associated with the COVID-19 pandemic. This is thanks to the commitment and hard work of students and staff at the UFS. 

Name behind the prize

The late Prof Bongani Mayosi was an outstanding doctor who rose rapidly through the ranks to become a top cardiologist, internationally recognised as a leading clinician scientist. He completed his undergraduate studies at the age of 22, having graduated cum laude in both the Bachelor of Medicine and Surgery (MB ChB) and Bachelor of Medical Sciences (BMedSci) degrees.

He trained as a physician and cardiologist at Groote Schuur Hospital and completed his doctorate at the University of Oxford in the UK. At the age of 38‚ he became the first black to be appointed professor and Head of the Department of Medicine at the University of Cape Town (UCT). In 2016, he was appointed Dean of the Faculty of Health Sciences at UCT. Before taking up his deanship, he completed the Advanced Management Programme at Harvard University in the US.

As a medical student Prof Mayosi excelled academically, was supportive of his classmates and enthusiastically involved in student residence committees and politics as well as community outreach programmes. As a researcher, he initiated an international programme of research focusing on solutions for poverty-related heart diseases and trained local clinician scientists and research leaders.

Prof Mayosi had an exceptional mixture of academic brilliance and vision; ambition and humility; kindness and generosity; passion and compassion; drive and empathy that complemented his ability to persuade and inspire others, which no doubt contributed to his 400 publications.

 

News Archive

Conference: Expanded ARV treatment
2005-03-02

VENUE: University of the Free State, Bloemfontein, South Africa
DATE: 30 March 2005 - 1 April 2005

  • ARV Programme as on 24Feb Download Word document
     
  • Programme Special events Download Word document


    Official web site www.fshealth.gov.za/subsites/arvc

     


    Rationale for the Conference
    At the time of the planned Conference, much ground would have been covered, both in the Free State and in South Africa, in respect of the expanded public sector ARV treatment programme in respect of research, experiences in practice, training of staff, treatment of patients, lessons learned, successes and failures, etc. The time would then be quite opportune to share these in a systematic manner with other provinces and countries, as well as with the large variety of stakeholders and role players in the ARV and related domains, be they academics and researchers, policy makers and service/facility managers, the variety of caregivers, and the community organisations and affected patients.

The Conference and current research
The proposed Conference is, firstly, directly linked to the current research on the public sector roll-out of ARV treatment in the Free State conducted by several research institutions (e.g. CIET, CHSR&D, UCT Lung Institute). Secondly, the Conference could and would serve as a forum for other research groups in the country and further a field to report and share knowledge and experiences on ARV treatment and related initiatives. Lastly, the Conference will stage a golden opportunity for researchers and scientists, on the one hand, and policy makers, managers, and caregivers (as knowledge users), on the other hand, to engage in cross-disciplinary discourse on this mutual and topical theme.

Theme of Conference
Expanded ARV treatment in the Free State: sharing experiences

Focus
The focus is primarily on public sector ARV treatment in the Free State, but also initiatives/activities/perspectives of relevance to the Free State elsewhere in the country at large and further a field, as well as relevant ARV initiatives in the public, private, NGO and FBO sectors. Bear in mind, however, that ARV treatment is but part of a much more comprehensive approach to HIV and AIDS. The Conference will, therefore, not narrowly focus on the ARV treatment programme only. The broader context, other relevant dimensions, and a comprehensive approach to the challenges of HIV, AIDS and TB are of equal importance.

The purpose of the Conference
Enhance meaningful exchange, mutual understanding and collaboration among researchers, scientists, policy makers, managers and practitioners in the field of ARV treatment and related fields.

Share experiences in the various spheres of ARV treatment and related spheres (policy, management, practice, research, training, public-private-civil society sectors).

Record, reflect and report on the establishment of the ARV treatment programme in the Free State, and in within the context of the comprehensive HIV/AIDS programme.

Disseminate important research results on ARV treatment and related themes to health policy makers, managers, practitioners, communities and to the research community.

Stimulate discourse among various disciplines and various stakeholders/role players involved in ARV treatment and related programmes.

Sensitise and acquaint researchers to the requirements of policy makers, managers and practitioners in respect of ARV treatment and related fields.

Facilitate the implementation of research results in ARV treatment policy, programmes and practice.

Dissemination of Conference-related information
Information generated during the Conference could feed into policy, management and practice of ARV treatment, the training accompanying such programme, and the existing body of knowledge. After the Conference the information will be disseminated via the Internet and by scientific and popular publications.

Date and duration
Set for 30 & 31 March & 1 April 2005; to commence at 09:00 on the first day (30 March) and to end at 16:30 (1 April) the third day.

Format and scope of Conference
Alternating plenary, parallel sessions and debates focused on topical issues and interest groups. The Conference will strive to be maximally interactive and participative.

Themes and topics to cover:

  • Policy, management and health services/practice (various levels and contexts – clinical treatment, information, IT systems, pharmacy, laboratories, nutrition)
     
  • Research covering all relevant disciplines and diverse dimensions of ARV treatment and related themes
  • Training and evaluation of training
  • Patients, communities and civil society organisations
  • Public, private, NGO, FBO initiatives and partnerships

Emphasis will be on the Free State, however, with of significant involvement from other provinces, SADC countries, and countries further a field. The thrust will be to export lessons and experiences from the Free State, but also to import lessons and experiences from other provinces, countries and sectors.

Presenters
Key presenters from the Free State, other provinces, South Africa, from the private, FBO and NGO sectors, and from several other countries

Delegates
About half of the delegates will be Free State stakeholders and role players (all levels and all contexts). The other half will be role players and stakeholders in the ARV and related fields from other provinces, the national level, and other countries, as well as from the private, public and non-governmental sectors.

Focused workshops
Provision will be made for half-a-day or one-day workshop initiatives on the third day (1 April 2005).

Enquiries
For more information please contact:

Prof Dingie van Rensburg
Centre for Health Systems Research & Development
University of the Free State
PO Box 339
Bloenfontein
SOUTH AFRICA
9300

Contact:
Carin van Vuuren
Conference Organiser
Centre for Health Systems Research & Development
University of the Free State
P.O.Box 339
Bloemfontein
South Africa
9300
Tel +27 (0) 51 401 2181
Fax +27 (0) 51 4480370
Cell 0832932890
e-mail: arvconference.hum@mail.uovs.ac.za

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept